Protocol T extension study details 5-year outcomes after anti-VEGF for DME

• Posted on: Oct 5 2020
• By: Saratoga Opthalmology
• Leave a response

This study assessed 5-year outcomes in eyes initially treated with anti-VEGF therapy for central-involved diabetic macular edema (DME) during a 2-year study.
Source: AAO

Posted in: Uncategorized